Christa J. Nehs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christa J. Nehs has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Dong Keon Yon
Department of Medicine Kyung Hee University College of Medicine Seoul South Korea
10 shared publications Fayaz A. Mir
Mass General Brigham Department of Anesthesiology, Massachusetts General Hospital and Harvard Medical School
6 shared publicationsJiseung Kang
School of Health and Environmental Science, Korea University College of Health Science, Seoul, South Korea; Department of Health and Safety Convergence Science, Korea University Graduate School, Seoul, South Korea
6 shared publications- Jiseung Kang
School of Health and Environmental Science Korea University College of Health Science Seoul South Korea
6 shared publications Arianna R. S. Lark
Mass General Brigham Department of Anesthesiology, Massachusetts General Hospital and Harvard Medical School
5 shared publicationsHyeon Jin Kim
Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea; Department of Precision Medicine, Kyung Hee University College of Medicine, Seoul, South Korea
5 shared publications
Latest Publications
- Open Access
Ketones and Sleep: A Narrative Review of Mechanisms, Preclinical Models, and Human Evidence
Background/Objectives: Sleep is a metabolically dynamic state, and ketone bodies may interact with sleep physiology as both oxidative substrates and signaling metabolites. β-Hydroxybutyrate (BHB), acetoacetate (AcAc), and acetone rise during fasting, carbohydrate restriction, ketogenic diets used for therapeutic or non-therapeutic purposes, prolonged exercise, selected pathological states of insulin deficiency, and after consumption of exogenous ketones. This narrative review synthesizes mechanistic, preclinical, and human evidence linking endogenously generated ketosis and ketosis generated from exogenous ketone consumption to sleep architecture, sleep quality, sleep-disordered breathing, and sleep-relevant metabolic pathways. Methods: We reviewed studies involving ketogenic diets, fasting or caloric restriction, and consumption of exogenous ketones, prioritizing investigations with polysomnography, electroencephalography (EEG), sleep architecture, respiratory, or validated sleep-questionnaire outcomes, while also considering mechanistic studies of neuronal excitability, inflammation, epigenetic regulation, circadian timing, and brain energetics. Results: The most direct preclinical evidence indicates that AcAc, but not BHB, increases slow-wave activity (delta power 0.5–4 Hz) during non-rapid eye movement (NREM) sleep and suppresses glutamate release in mice, supporting a potential role for ketone metabolism in sleep homeostasis. Dietary, fasting, and aging models further suggest that lipid/ketone metabolism can alter NREM/rapid eye movement (REM) balance, circadian metabolic rhythms, and sleep–wake responses to energetic stress, with aged-rat data showing sex-specific REM and cognitive effects of ketogenic interventions. Human studies are suggestive but heterogeneous: acute carbohydrate restriction can increase slow-wave sleep and reduce REM sleep in healthy adults; ketogenic therapies may improve subjective sleep in selected neurological and metabolic populations; and ketone ester ingestion can improve sleep efficiency after strenuous evening exercise, but not during hypoxia-induced sleep disruption. Conclusions: Ketones are sleep-relevant metabolic signals, but their effects are conditional rather than universally sleep-promoting. They may also indirectly affect sleep by enhancing wakefulness quality. The ketone concentration range associated with optimal sleep outcomes remains undefined, and potential dose-, timing-, and context-dependent effects on sleep require further study. Future studies should distinguish AcAc from BHB biology, measure nocturnal ketone dynamics, incorporate PSG/EEG spectral endpoints, and separate ketosis-specific effects from weight loss, energy deficit, exercise load, respiratory physiology, circadian timing, and disease-related confounders.
Open AccessKetones and Sleep: A Narrative Review of Mechanisms, Preclinical Models, and Human Evidence
Background/Objectives: Sleep is a metabolically dynamic state, and ketone bodies may interact with sleep physiology as both oxidative substrates and signaling metabolites. β-Hydroxybutyrate (BHB), acetoacetate (AcAc), and acetone rise during fasting, carbohydrate restriction, ketogenic diets used for therapeutic or non-therapeutic purposes, prolonged exercise, selected pathological states of insulin deficiency, and after consumption of exogenous ketones. This narrative review synthesizes mechanistic, preclinical, and human evidence linking endogenously generated ketosis and ketosis generated from exogenous ketone consumption to sleep architecture, sleep quality, sleep-disordered breathing, and sleep-relevant metabolic pathways. Methods: We reviewed studies involving ketogenic diets, fasting or caloric restriction, and consumption of exogenous ketones, prioritizing investigations with polysomnography, electroencephalography (EEG), sleep architecture, respiratory, or validated sleep-questionnaire outcomes, while also considering mechanistic studies of neuronal excitability, inflammation, epigenetic regulation, circadian timing, and brain energetics. Results: The most direct preclinical evidence indicates that AcAc, but not BHB, increases slow-wave activity (delta power 0.5–4 Hz) during non-rapid eye movement (NREM) sleep and suppresses glutamate release in mice, supporting a potential role for ketone metabolism in sleep homeostasis. Dietary, fasting, and aging models further suggest that lipid/ketone metabolism can alter NREM/rapid eye movement (REM) balance, circadian metabolic rhythms, and sleep–wake responses to energetic stress, with aged-rat data showing sex-specific REM and cognitive effects of ketogenic interventions. Human studies are suggestive but heterogeneous: acute carbohydrate restriction can increase slow-wave sleep and reduce REM sleep in healthy adults; ketogenic therapies may improve subjective sleep in selected neurological and metabolic populations; and ketone ester ingestion can improve sleep efficiency after strenuous evening exercise, but not during hypoxia-induced sleep disruption. Conclusions: Ketones are sleep-relevant metabolic signals, but their effects are conditional rather than universally sleep-promoting. They may also indirectly affect sleep by enhancing wakefulness quality. The ketone concentration range associated with optimal sleep outcomes remains undefined, and potential dose-, timing-, and context-dependent effects on sleep require further study. Future studies should distinguish AcAc from BHB biology, measure nocturnal ketone dynamics, incorporate PSG/EEG spectral endpoints, and separate ketosis-specific effects from weight loss, energy deficit, exercise load, respiratory physiology, circadian timing, and disease-related confounders.
- Open Access
- 13 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1004829
Maternal opioid prescriptions and subsequent risk of hospital admission in offspring in South Korea: A nationwide birth cohort study
Background: Prenatal opioid exposure may disrupt infant development and immune system function, potentially increasing long-term susceptibility to hospital admissions. Thus, we aimed to investigate the association between prenatal opioid exposure and the risk of hospital admission in children. Methods and findings: We established a population-based birth cohort in South Korea by linking mothers and children using National Health Insurance Service data and followed from January 1, 2009, to December 31, 2023. We constructed propensity score (PS)-matched and sibling comparison cohorts and performed a multi-pronged approach, including dose-dependent and time-attenuation analyses. All 5,249,429 individuals with eligible children born between January 1, 2010, and December 31, 2017, were included (2,236,167 mothers and 3,013,262 children). Infants were followed up for up to 14 years, depending on birth year. Prenatal exposure to opioids was defined as maternal receipt of two or more prescriptions within any given trimester. Adjusted incidence rate ratio (aIRR) of hospital admission among children with prenatal opioid exposure was estimated for causes including infections, non-infectious respiratory conditions, non-infectious gastrointestinal conditions, oral cavity diseases, injuries/external causes, and non-infectious genitourinary conditions. Analyses were adjusted for maternal age at delivery, infant sex, region of residence, household income level, birth season, parity, severe maternal morbidity score, number of outpatient visits and hospital admissions in the year before pregnancy, preterm birth, low birth weight, delivery type, year of delivery, maternal history of substance use and neuropsychiatric disorders, and plurality. Of the 2,928,186 children, we identified 2,809,515 (51.4% male) and 118,671 (51.3% male) infants without and with prenatal opioid exposure, respectively. The rate of hospital admissions in children with prenatal opioid exposure was 28% higher in the PS-matched cohort (aIRR 1.28 [95% CI 1.28, 1.29]; p < 0.001). The association was attenuated in the sibling comparison cohort, indicating the potential influence of shared familial factors, but remained statistically significant (aIRR 1.08 [95% CI 1.07, 1.10]; p < 0.001). Hospital admission rates in children increased in a dose-dependent manner with maternal opioid dose and duration of opioid prescriptions (low-dose exposure: aIRR 1.19 [95% CI 1.19, 1.20]; p < 0.001; high-dose exposure: aIRR 1.40 [95% CI 1.39, 1.41]; p < 0.001). Prenatal opioid exposure was significantly associated with increased rates of hospital admission across several causes of morbidities, including infections, respiratory non-infections, oral cavity, gastrointestinal non-infections, genitourinary non-infections, and injury/external conditions. These associations between prenatal opioid exposure and hospital admission rates in children diminished with age but remained evident up to five years of age. The main limitations of this study’s methodology include the use of prescription records, which may not fully capture actual medication intake, and residual confounding that cannot be entirely excluded. Conclusions: In this nationwide birth cohort study, maternal opioid prescription during pregnancy was associated with a substantial increase in the risk of hospital admissions in the offspring across various causes of morbidities. Although the attenuated estimates in the sibling comparison analysis suggest that familial factors may partly explain this association, these findings may inform postnatal monitoring and management strategies for children born to mothers who received opioid prescriptions during pregnancy.
- 13 October 2026
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 23 (10) , e1004829
Open AccessMaternal opioid prescriptions and subsequent risk of hospital admission in offspring in South Korea: A nationwide birth cohort study
Background: Prenatal opioid exposure may disrupt infant development and immune system function, potentially increasing long-term susceptibility to hospital admissions. Thus, we aimed to investigate the association between prenatal opioid exposure and the risk of hospital admission in children. Methods and findings: We established a population-based birth cohort in South Korea by linking mothers and children using National Health Insurance Service data and followed from January 1, 2009, to December 31, 2023. We constructed propensity score (PS)-matched and sibling comparison cohorts and performed a multi-pronged approach, including dose-dependent and time-attenuation analyses. All 5,249,429 individuals with eligible children born between January 1, 2010, and December 31, 2017, were included (2,236,167 mothers and 3,013,262 children). Infants were followed up for up to 14 years, depending on birth year. Prenatal exposure to opioids was defined as maternal receipt of two or more prescriptions within any given trimester. Adjusted incidence rate ratio (aIRR) of hospital admission among children with prenatal opioid exposure was estimated for causes including infections, non-infectious respiratory conditions, non-infectious gastrointestinal conditions, oral cavity diseases, injuries/external causes, and non-infectious genitourinary conditions. Analyses were adjusted for maternal age at delivery, infant sex, region of residence, household income level, birth season, parity, severe maternal morbidity score, number of outpatient visits and hospital admissions in the year before pregnancy, preterm birth, low birth weight, delivery type, year of delivery, maternal history of substance use and neuropsychiatric disorders, and plurality. Of the 2,928,186 children, we identified 2,809,515 (51.4% male) and 118,671 (51.3% male) infants without and with prenatal opioid exposure, respectively. The rate of hospital admissions in children with prenatal opioid exposure was 28% higher in the PS-matched cohort (aIRR 1.28 [95% CI 1.28, 1.29]; p < 0.001). The association was attenuated in the sibling comparison cohort, indicating the potential influence of shared familial factors, but remained statistically significant (aIRR 1.08 [95% CI 1.07, 1.10]; p < 0.001). Hospital admission rates in children increased in a dose-dependent manner with maternal opioid dose and duration of opioid prescriptions (low-dose exposure: aIRR 1.19 [95% CI 1.19, 1.20]; p < 0.001; high-dose exposure: aIRR 1.40 [95% CI 1.39, 1.41]; p < 0.001). Prenatal opioid exposure was significantly associated with increased rates of hospital admission across several causes of morbidities, including infections, respiratory non-infections, oral cavity, gastrointestinal non-infections, genitourinary non-infections, and injury/external conditions. These associations between prenatal opioid exposure and hospital admission rates in children diminished with age but remained evident up to five years of age. The main limitations of this study’s methodology include the use of prescription records, which may not fully capture actual medication intake, and residual confounding that cannot be entirely excluded. Conclusions: In this nationwide birth cohort study, maternal opioid prescription during pregnancy was associated with a substantial increase in the risk of hospital admissions in the offspring across various causes of morbidities. Although the attenuated estimates in the sibling comparison analysis suggest that familial factors may partly explain this association, these findings may inform postnatal monitoring and management strategies for children born to mothers who received opioid prescriptions during pregnancy.
- 15 May 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 411, 121971
Genetic confounding in the association between obesity-related phenotypes and neuropsychiatric disorders
- 15 May 2026
- Published by Elsevier in Journal of Affective Disorders
- Vol. 411, 121971
Genetic confounding in the association between obesity-related phenotypes and neuropsychiatric disorders
- Open Access
- 25 April 2026
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (4) , 556-575
Long-Term Trends in Counseling for Stress and Depression Among Adults, 2009–2024, Considering the Impact of COVID-19 Pandemic: A Nationwide Representative Study in South Korea
Objective Despite the impact of the COVID-19 pandemic on global mental health, few studies have examined changes in the demand for mental health counseling over time. This study investigated 16-year national trends in counseling for stress and depression in South Korea, with a focus on the pandemic’s impact and evolving population-level risk factors.Methods This study analyzed trends in stress and depression counseling using data from 3,195,912 Korean adults in the Korea Community Health Survey (2009–2024). Counseling was defined by self-reported responses. The period was categorized as pre-pandemic (2009–2019), intra-pandemic (2020–2022), and post-pandemic (2023–2024). Weighted logistic regression was used to assess prevalence trends, high-risk groups, and changes in risk patterns over time.Results The prevalence of counseling for stress steadily increased from 1.54% (2009–2010) to 2.16% (2017–2019), peaked at 3.06% in 2022 during the pandemic, and remained elevated at 2.97% in 2023–2024. Depression counseling showed a similar pattern. Higher rates were consistently observed among young adults, women, those with poor self-rated health, and individuals with sleep <6 or ≥8 hours. Notably, while low education was a key pre-pandemic risk factor, counseling increased more among highly educated individuals during the pandemic.Conclusion The COVID-19 pandemic affected mental health counseling in South Korea and led to the emergence of new at-risk groups. Sustained high counseling rates among young adults and the highly educated highlight the need for targeted, population-specific interventions.
- 25 April 2026
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (4) , 556-575
Open AccessLong-Term Trends in Counseling for Stress and Depression Among Adults, 2009–2024, Considering the Impact of COVID-19 Pandemic: A Nationwide Representative Study in South Korea
Objective Despite the impact of the COVID-19 pandemic on global mental health, few studies have examined changes in the demand for mental health counseling over time. This study investigated 16-year national trends in counseling for stress and depression in South Korea, with a focus on the pandemic’s impact and evolving population-level risk factors.Methods This study analyzed trends in stress and depression counseling using data from 3,195,912 Korean adults in the Korea Community Health Survey (2009–2024). Counseling was defined by self-reported responses. The period was categorized as pre-pandemic (2009–2019), intra-pandemic (2020–2022), and post-pandemic (2023–2024). Weighted logistic regression was used to assess prevalence trends, high-risk groups, and changes in risk patterns over time.Results The prevalence of counseling for stress steadily increased from 1.54% (2009–2010) to 2.16% (2017–2019), peaked at 3.06% in 2022 during the pandemic, and remained elevated at 2.97% in 2023–2024. Depression counseling showed a similar pattern. Higher rates were consistently observed among young adults, women, those with poor self-rated health, and individuals with sleep <6 or ≥8 hours. Notably, while low education was a key pre-pandemic risk factor, counseling increased more among highly educated individuals during the pandemic.Conclusion The COVID-19 pandemic affected mental health counseling in South Korea and led to the emergence of new at-risk groups. Sustained high counseling rates among young adults and the highly educated highlight the need for targeted, population-specific interventions.
- Open Access
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1797686
Ketogenic interventions enhance REM sleep in females and support memory in aged rats
Introduction: Sleep disruption and metabolic decline are key contributors to cognitive aging and dementia risk. While cerebral glucose utilization declines with age, ketone metabolism remains relatively preserved, suggesting that ketogenic interventions may enhance brain energetics, sleep quality, and cognition in older individuals. Therefore, we investigated the effects of a ketogenic diet (KD) and β -hydroxybutyrate ester (KE) supplementation on sleep–wake architecture and novel spatial memory following sleep deprivation in aged rats. Methods: Forty four aged (22–25-month-old) Fischer-344 rats were implanted with frontoparietal EEG and nuchal EMG electrodes for wireless sleep recordings. Following baseline assessment, rats received either KE gavage (2.5 g/kg) or water control or were fed a KD versus control diet for 2 months. Sleep stages were scored using AccuSleep, cognition was assessed using the novel place preference task, and postmortem immunohistochemistry was performed to assess oxidative stress and inflammation. Results: Both KE ( p = 0.0152) and KD ( p = 0.0385) significantly increased REM sleep in aged female rats, with KE enhancing REM during the light phase and KD during the dark phase. Whereas, KE decreased REM sleep in males during the light phase ( p = 0.00165). KD increased the number of REM sleep bouts without altering bout duration in females, consistent with enhanced REM sleep initiation rather than maintenance. EEG spectral analysis revealed no differences in NREM delta power or REM theta power in KD females, suggesting preserved microarchitecture. Sleep deprivation did not change spatial memory in our rats but KD treated rats showed improved novel place recognition in both females and males ( p < 0.001). Immunohistochemistry revealed reduced lipid peroxidation (4-HNE) without changes in protein oxidation (3-NT) or NLRP3 expression, while TREM2 was selectively reduced in KD females. This pattern is consistent with altered microglial lipid handling rather than broad suppression of inflammatory signaling. In contrast, aged male rats showed no significant changes in sleep architecture or molecular markers. Discussion: Together, these findings demonstrate that ketone-based interventions selectively enhance REM sleep, reduce lipid-associated oxidative stress in aged female rats and improve novelty preference memory in both sexes. These data highlight a sex-dependent relationship between metabolic flexibility, REM sleep regulation, and cognitive aging, supporting ketone-based strategies as targeted interventions for promoting healthy brain aging.
- 10 April 2026
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 18, 1797686
Open AccessKetogenic interventions enhance REM sleep in females and support memory in aged rats
Introduction: Sleep disruption and metabolic decline are key contributors to cognitive aging and dementia risk. While cerebral glucose utilization declines with age, ketone metabolism remains relatively preserved, suggesting that ketogenic interventions may enhance brain energetics, sleep quality, and cognition in older individuals. Therefore, we investigated the effects of a ketogenic diet (KD) and β -hydroxybutyrate ester (KE) supplementation on sleep–wake architecture and novel spatial memory following sleep deprivation in aged rats. Methods: Forty four aged (22–25-month-old) Fischer-344 rats were implanted with frontoparietal EEG and nuchal EMG electrodes for wireless sleep recordings. Following baseline assessment, rats received either KE gavage (2.5 g/kg) or water control or were fed a KD versus control diet for 2 months. Sleep stages were scored using AccuSleep, cognition was assessed using the novel place preference task, and postmortem immunohistochemistry was performed to assess oxidative stress and inflammation. Results: Both KE ( p = 0.0152) and KD ( p = 0.0385) significantly increased REM sleep in aged female rats, with KE enhancing REM during the light phase and KD during the dark phase. Whereas, KE decreased REM sleep in males during the light phase ( p = 0.00165). KD increased the number of REM sleep bouts without altering bout duration in females, consistent with enhanced REM sleep initiation rather than maintenance. EEG spectral analysis revealed no differences in NREM delta power or REM theta power in KD females, suggesting preserved microarchitecture. Sleep deprivation did not change spatial memory in our rats but KD treated rats showed improved novel place recognition in both females and males ( p < 0.001). Immunohistochemistry revealed reduced lipid peroxidation (4-HNE) without changes in protein oxidation (3-NT) or NLRP3 expression, while TREM2 was selectively reduced in KD females. This pattern is consistent with altered microglial lipid handling rather than broad suppression of inflammatory signaling. In contrast, aged male rats showed no significant changes in sleep architecture or molecular markers. Discussion: Together, these findings demonstrate that ketone-based interventions selectively enhance REM sleep, reduce lipid-associated oxidative stress in aged female rats and improve novelty preference memory in both sexes. These data highlight a sex-dependent relationship between metabolic flexibility, REM sleep regulation, and cognitive aging, supporting ketone-based strategies as targeted interventions for promoting healthy brain aging.
- Top Cited PapersOpen Access
- 23 February 2026
- Published by Wiley in Obesity Reviews
- Vol. 27 (7) , e70102
Gestational Diabetes Mellitus and Adverse Maternal and Neonatal Health Outcomes: an Umbrella review of Meta‐Analyses
Introduction: This study systematically synthesized evidence on adverse health outcomes related to gestational diabetes mellitus (GDM) via an umbrella review with integrated meta‐analyses. Methods: The search covered publications from the database (PubMed/MEDLINE, Google Scholar, Embase, and CINAHL) inception to August 12, 2024. Meta‐analyses of observational studies examining the impact of GDM on maternal and neonatal health outcomes were included. Two independent researchers screened and extracted data. Associations were reanalyzed and presented as equivalent odds ratios (eORs) with 95% confidence intervals (CI). The quality of meta‐analyses was assessed using AMSTAR 2, and the credibility of associations was categorized into five levels: convincing (Class I), highly suggestive (Class II), suggestive (Class III), weak (Class IV), or nonsignificant (NS). Results: A total of 27 meta‐analyses encompassing 85 associations were included. Among 28 significant maternal outcomes, 11 (subclinical atherosclerosis, angina, hypertension, overall cardiovascular diseases, ischemic stroke, overall stroke, combined cardiovascular/cerebrovascular diseases, subclinical left ventricle systolic dysfunction, type 2 diabetes, postpartum metabolic syndrome, and infections) were supported by convincing or highly suggestive evidence. Of 13 significant neonatal outcomes, three (atrial septal defect, congenital heart disease, and ventricular septal defect) were highly suggestive, while four of eight significant delivery outcomes (hypertensive disorders, cesarean delivery, admission to neonatal intensive care unit admission, and preterm birth) reached this level. Notably, no outcomes previously deemed nonsignificant turned significant upon reanalysis. Conclusions: These findings underscore the need for targeted prevention and management, and further research is needed to clarify causality and refine guidelines. Study registration: PROSPERO CRD42024590322
- 23 February 2026
- Published by Wiley in Obesity Reviews
- Vol. 27 (7) , e70102
Top Cited PapersOpen AccessGestational Diabetes Mellitus and Adverse Maternal and Neonatal Health Outcomes: an Umbrella review of Meta‐Analyses
Introduction: This study systematically synthesized evidence on adverse health outcomes related to gestational diabetes mellitus (GDM) via an umbrella review with integrated meta‐analyses. Methods: The search covered publications from the database (PubMed/MEDLINE, Google Scholar, Embase, and CINAHL) inception to August 12, 2024. Meta‐analyses of observational studies examining the impact of GDM on maternal and neonatal health outcomes were included. Two independent researchers screened and extracted data. Associations were reanalyzed and presented as equivalent odds ratios (eORs) with 95% confidence intervals (CI). The quality of meta‐analyses was assessed using AMSTAR 2, and the credibility of associations was categorized into five levels: convincing (Class I), highly suggestive (Class II), suggestive (Class III), weak (Class IV), or nonsignificant (NS). Results: A total of 27 meta‐analyses encompassing 85 associations were included. Among 28 significant maternal outcomes, 11 (subclinical atherosclerosis, angina, hypertension, overall cardiovascular diseases, ischemic stroke, overall stroke, combined cardiovascular/cerebrovascular diseases, subclinical left ventricle systolic dysfunction, type 2 diabetes, postpartum metabolic syndrome, and infections) were supported by convincing or highly suggestive evidence. Of 13 significant neonatal outcomes, three (atrial septal defect, congenital heart disease, and ventricular septal defect) were highly suggestive, while four of eight significant delivery outcomes (hypertensive disorders, cesarean delivery, admission to neonatal intensive care unit admission, and preterm birth) reached this level. Notably, no outcomes previously deemed nonsignificant turned significant upon reanalysis. Conclusions: These findings underscore the need for targeted prevention and management, and further research is needed to clarify causality and refine guidelines. Study registration: PROSPERO CRD42024590322
- 21 February 2026
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 144, 106187
Step counts over time with the burden of 105 non-communicable diseases in older adults from the All of Us Research Program
- 21 February 2026
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 144, 106187
Step counts over time with the burden of 105 non-communicable diseases in older adults from the All of Us Research Program
- Open Access
- 25 January 2026
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (1) , 118-129
Association of Everyday Discrimination With Drug Use During the COVID-19 Pandemic in the All of Us Research Program
Objective Recognizing discrimination as a significant public health risk during the coronavirus disease 2019 (COVID-19) pandemic, which coincided with increased drug use and heightened awareness of structural disparities in the United States, we investigated its association with the odds of drug use in a large and diverse cohort from the All of Us Research Program.Methods In this cross-sectional study, data from 68,976 participants completed the COVID-19 participant experiences (COPE) survey. We applied logistic regression models with propensity score-based overlap weighting to examine associations between everyday discrimination and drug use. Self-reported everyday discrimination score and drug use were the primary exposure and outcome measures, respectively.Results Of the 67,662 COPE respondents (mean [standard deviation] age, 57.5 [15.9] years; female sex at birth, 43,658 [64.5%]), we identified 15,493 participants with no reported discrimination and 15,493 participants with reported discrimination, after overlap weighting. The odds of drug use in those who reported discrimination was 1.38 (95% confidence interval, 1.32–1.43), with a dose-dependent association based on discrimination score. Participants who experienced discrimination had significantly higher odds of using drugs and this association was particularly pronounced in those under 40 years of age, those assigned female sex at birth, current smokers, individuals undergoing chemotherapy or immunotherapy, and those experiencing unemployment or COVID-19/flu-like symptoms.Conclusion This relationship was observed across various types of drugs and different reasons for discrimination, and it was particularly pronounced in specific subgroups. These findings provide critical evidence for developing targeted preventive interventions; however, further longitudinal studies for causality are warranted.
- 25 January 2026
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 23 (1) , 118-129
Open AccessAssociation of Everyday Discrimination With Drug Use During the COVID-19 Pandemic in the All of Us Research Program
Objective Recognizing discrimination as a significant public health risk during the coronavirus disease 2019 (COVID-19) pandemic, which coincided with increased drug use and heightened awareness of structural disparities in the United States, we investigated its association with the odds of drug use in a large and diverse cohort from the All of Us Research Program.Methods In this cross-sectional study, data from 68,976 participants completed the COVID-19 participant experiences (COPE) survey. We applied logistic regression models with propensity score-based overlap weighting to examine associations between everyday discrimination and drug use. Self-reported everyday discrimination score and drug use were the primary exposure and outcome measures, respectively.Results Of the 67,662 COPE respondents (mean [standard deviation] age, 57.5 [15.9] years; female sex at birth, 43,658 [64.5%]), we identified 15,493 participants with no reported discrimination and 15,493 participants with reported discrimination, after overlap weighting. The odds of drug use in those who reported discrimination was 1.38 (95% confidence interval, 1.32–1.43), with a dose-dependent association based on discrimination score. Participants who experienced discrimination had significantly higher odds of using drugs and this association was particularly pronounced in those under 40 years of age, those assigned female sex at birth, current smokers, individuals undergoing chemotherapy or immunotherapy, and those experiencing unemployment or COVID-19/flu-like symptoms.Conclusion This relationship was observed across various types of drugs and different reasons for discrimination, and it was particularly pronounced in specific subgroups. These findings provide critical evidence for developing targeted preventive interventions; however, further longitudinal studies for causality are warranted.